(Q35174218)

6 August 2017

1 reference

title

Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma (English)

1 reference

6 August 2017

0 references

2

Donald P Tashkin

1 reference

6 August 2017

1

Jonathan Corren

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

published in

Clinical Therapeutics

1 reference

6 August 2017

volume

25

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

776-798

1 reference

Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Alveolar tissue inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The evolution of inhaler technology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Improved delivery of inhaled steroids to the large and small airways

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Therapeutic significance of distal airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Use of spacers to facilitate inhaled corticosteroid treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Poor inhalation technique, even after inhalation instructions, in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Cellular events in the bronchi in mild asthma and after bronchial provocation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Quantitative structural alterations in long-standing allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The structure of large and small airways in nonfatal and fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The distal airways: are they important in asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Airway hyperreactivity: assessment with helical thin-section CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Inflammation of small airways in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Peripheral lung resistance in normal and asthmatic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Spirometric patterns in childhood asthma: peak flow compared with other indices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Spirometry in the asthmatic child: is FEF25-75 a more sensitive test than FEV1/FVC?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Small airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

A model of airway narrowing in asthma and in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Direct assessment of small airways reactivity in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Inflammatory cell distribution within and along asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The relations between structural changes in small airways and pulmonary-function tests

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Changes in risk of hospital readmission among asthmatic children in Denmark, 1978-93

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Comparison of four-times-a-day and twice-a-day dosing regimens in subjects requiring 1200 micrograms or less of budesonide to control mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Small airways and asthma. An important therapeutic target?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Growth of asthmatic children during treatment with budesonide: a double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

Clinical longitudinal standards for height and height velocity for North American children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980108-X

7 January 2021

10.1016/S0149-2918(03)80108-X

Identifiers

DOI

1 reference

6 August 2017

1 reference